Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19
Authors
Keywords
-
Journal
JAMA Network Open
Volume 4, Issue 3, Pages e213594
Publisher
American Medical Association (AMA)
Online
2021-03-31
DOI
10.1001/jamanetworkopen.2021.3594
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19
- (2020) Reinhold Kreutz et al. CARDIOVASCULAR RESEARCH
- Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin–angiotensin system inhibitors
- (2020) Xian Zhou et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- Clinical Impact of Renin-angiotensin System Inhibitors on In-hospital Mortality of Patients With Hypertension Hospitalized for Coronavirus Disease 2019
- (2020) Sara Tedeschi et al. CLINICAL INFECTIOUS DISEASES
- Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study
- (2020) Sun-Young Jung et al. CLINICAL INFECTIOUS DISEASES
- Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
- (2020) Bo Li et al. Clinical Research in Cardiology
- Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
- (2020) Yuchen Chen et al. DIABETES CARE
- Coronaviruses and the cardiovascular system: acute and long-term implications
- (2020) Tian-Yuan Xiong et al. EUROPEAN HEART JOURNAL
- Associations between Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality among Patients with COVID-19
- (2020) Nian-Di Tan et al. GASTROENTEROLOGY
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome
- (2020) Jianhua Hu et al. JOURNAL OF INFECTION
- Ramipril in High Risk Patients with COVID-19
- (2020) Ignacio J. Amat-Santos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
- (2020) Francisco J de Abajo et al. LANCET
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)
- (2020) Neil Mehta et al. JAMA Cardiology
- Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Tao Guo et al. JAMA Cardiology
- Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China
- (2020) Juyi Li et al. JAMA Cardiology
- Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed with COVID-19
- (2020) David J. Bae et al. AMERICAN JOURNAL OF CARDIOLOGY
- Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?
- (2020) Murat Selçuk et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study
- (2020) Chao Gao et al. EUROPEAN HEART JOURNAL
- Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
- (2020) Julia Hippisley-Cox et al. HEART
- Baseline use of angiotensin-converting enzyme inhibitor/AT1 blocker and outcomes in hospitalized coronavirus disease 2019 African-American patients
- (2020) Priyank Shah et al. JOURNAL OF HYPERTENSION
- Continued in-hospital ACE inhibitor and ARB Use in hypertensive COVID-19 patients is associated with positive clinical outcomes
- (2020) Katherine W Lam et al. JOURNAL OF INFECTIOUS DISEASES
- Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study
- (2020) Jong-moon Hwang et al. NEUROLOGICAL SCIENCES
- Could anti‐hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID‐19 infection? Data from centers of southern Italy
- (2020) Celestino Sardu et al. Journal of the American Heart Association
- Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis
- (2020) Jiuyang Xu et al. Frontiers of Medicine
- Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients
- (2020) Ranu Baral et al. Current Atherosclerosis Reports
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients
- (2020) Gianluca Trifirò et al. DRUG SAFETY
- Renin–angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study
- (2020) Yasushi Matsuzawa et al. HYPERTENSION RESEARCH
- Association between renin–angiotensin–aldosterone system inhibitor treatment, neutrophil–lymphocyte ratio, D-Dimer and clinical severity of COVID-19 in hospitalized patients: a multicenter, observational study
- (2020) Selcuk Gormez et al. JOURNAL OF HUMAN HYPERTENSION
- Angiotensin converting enzyme inhibitors do not increase the risk of poor outcomes in COVID-19 disease. A multi-centre observational study
- (2020) Khurram Shahzad Khan et al. SCOTTISH MEDICAL JOURNAL
- Mortality and Pre‐Hospitalization use of Renin‐Angiotensin System Inhibitors in Hypertensive COVID‐19 Patients
- (2020) Chen Chen et al. Journal of the American Heart Association
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Closing the Gap between Methodologists and End-Users:Ras a Computational Back-End
- (2015) Byron C. Wallace et al. Journal of Statistical Software
- Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker
- (2014) M. Furuhashi et al. AMERICAN JOURNAL OF HYPERTENSION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started